The Food and Drug Administration (FDA) has cleared the Kimberly-Clark pediatric/child face mask, designed to be worn in hospitals and healthcare facilities to help reduce the spread of airborne respiratory tract bacteria, viruses, and other pathogens.
The mask is designed to fit children ages 5 years to 12 years. Children do not breathe as forcefully as adults, particularly children with respiratory infections, so the face mask is less resistant to airflow than an adult mask.
"Children are not small adults," says Susan Cummins, MD, chief pediatric medical officer at FDAs Center for Devices and Radiological Health. "This pediatric face mask helps fill an unmet need for medical devices that are specifically designed for childrens unique anatomy and growing bodies."
Performance tests reviewed by the FDA showed that air flow and filtering ability of the mask were appropriate for children. The mask, cleared on Sept. 23, 2011, includes specific fitting instructions for the adult who assists the child in using the device. Adult supervision of any child wearing a face mask is an important safety recommendation.
The mask should not be used on patients showing signs of shortness of breath, chest pain, chest pressure, indrawing of the lower chest wall, dizziness, or confusion.
CDC HICPAC Considers New Airborne Pathogen Guidelines Amid Growing Concerns
November 18th 2024The CDC HICPAC discussed updates to airborne pathogen guidelines, emphasizing the need for masks in health care. Despite risks, the committee resisted universal masking, highlighting other mitigation strategies
Breaking the Cycle: Long COVID's Impact and the Urgent Need for Preventative Measures
November 15th 2024Masking, clean air, and vaccinations are essential in combating COVID-19 and preventing long-term impacts, as evidence mounts of long COVID's significant economic, cognitive, and behavioral effects.
The Critical Role of Rapid Diagnostics in Antibiotic Stewardship
November 6th 2024Rapid diagnostics enhance patient outcomes by enabling prompt, targeted treatments, reducing inappropriate antibiotic use, and combating antimicrobial resistance through informed clinical decisions and stewardship programs.